A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease
Launched by ADI NEGEV-NAHALAT ERAN · Dec 11, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new rehabilitation program designed specifically for people with Parkinson's disease. The program uses robots and music to help improve both movement and thinking skills while participants sit comfortably. Researchers want to see how well this gamified system works by gathering feedback from the users and measuring their physical and mental performance.
To join the study, participants need to be between the ages of 50 and 75, speak Hebrew, and have a diagnosis of Idiopathic Parkinson's disease but not more severe forms of it. They should also have a certain level of cognitive ability, as assessed by a simple test. Participants will engage with the robotic system and share their experiences, helping researchers understand its effectiveness. If you or a loved one are interested, please know there are a few conditions that may prevent participation, such as having other neurological issues or severe vision or hearing problems.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signing the informed consent form
- • Men and women in ages 50-75
- • Hebrew speakers
- • Have Idiopathic Parkinson's disease
- • Hoehn and Yahr 3 and below
- • Moca test 23 and above
- Exclusion Criteria:
- • Patients with Parkinson's plus syndromes
- • PD patients who suffer from unrelated neurological symptoms.
- • Orthopedic problems of the upper limb
- • Recent surgery conducted on the upper limb
- • Uncorrected vision problems
- • Uncorrected severe hearing loss
About Adi Negev Nahalat Eran
Adi Negev-Nahalat Eran is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions for individuals with complex neuropsychiatric conditions. With a strong commitment to research excellence and patient-centered care, the organization collaborates with leading academic institutions and healthcare providers to design and conduct rigorous clinical studies. Their focus on evidence-based approaches aims to enhance treatment outcomes and improve the quality of life for patients, while also contributing to the broader scientific community through the dissemination of research findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ofakim, South, Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported